Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML - HSA Drug Approval Details

Approvals/HSA/LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML

Approved

STANDARD

LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML

Unknown🇸🇬 Health Sciences Authority

Approval Date: Jan 13, 2026
Approval ID: 1faab7bc2f5f0f09
Company: Unknown
Type: Standard

Approval Details

Approval Id: 1faab7bc2f5f0f09
Drug Name: LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML

Active Ingredients

Lutetium (177Lu) oxodotreotide

370 Mbq/ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 13, 2026

Approval ID

1faab7bc2f5f0f09

Type

Standard

Back to HSA Approvals